electrovac AG Reports Significant Growth in Revenue and Earnings in the 2025/2026 Financial Year Based on Preliminary Figures

electrovac reported preliminary FY2025/26 results with revenue up ~20% to ~EUR 118.0M (from EUR 98.2M) and EBIT up ~56% to ~EUR 14.2M, lifting the EBIT margin to ~12.0% (from 9.3%). It also cited strong order intake (Q1 2026/27 revenue ~EUR 31.5M, ~+14% YoY) driven by Aerospace & Defence and Personal Safety demand, plus capacity expansion in Thailand and positive pricing effects. Audited statements are due 14 Aug 2026, with an earnings call the same day.

Analysis

The market implication is less about one niche supplier and more about the persistence of demand in qualified defense/safety components. That tends to matter because once a customer platform is validated, revenue is sticky and pricing can hold better than in commodity electronics; the real second-order winner is the wider European defense/avionics supply chain, where capacity-constrained sub-tier vendors can keep raising lead times and mix, supporting margins across the chain.

Near term, this can support a rerating into the August audit and call, but the setup is fragile because small-cap preliminary releases often overstate durability. The key test is whether order strength converts into cash flow and backlog quality; if the next update shows normalization in book-to-bill or weaker incremental margins once IPO costs wash out, the move can fade quickly. A clean falsifier would be guidance that growth decelerates back to low double digits or margins stall below the 12% area.

Contrarian view: consensus may be underestimating the value of the Thailand capacity expansion, which can turn a good demand environment into operating leverage rather than just revenue growth. But it may also be overcalling structural share gains from a single quarter of strong orders; defense bookings are lumpy, and industrial demand can mask cyclicality. If the current run-rate persists for 6-18 months, this becomes a quality-growth story; if not, it is just post-IPO follow-through with limited duration.

Key Decisions for Investors

• Long ITA / short XLI for 1-3 months as a relative-value expression of defense electronics demand outperforming broader industrials; target 5-8% relative outperformance, invalidated if defense primes guide down capex or European order momentum softens.
• Buy PPA on any post-announcement weakness and hold into the 14 Aug audited release; use a tight stop if the stock fails to hold the initial breakout for more than 2-3 sessions, because the thesis depends on confirmation of backlog quality.
• Watch MTRN and GLW as secondary beneficiaries of the qualified-components cycle; do not buy aggressively until the August call confirms whether pricing gains are repeatable, since the current release does not yet prove sustainable margin expansion.
• If electrovac-like order strength shows up in peers on earnings, add to defense supply-chain exposure over the next 1-3 months; if book-to-bill trends back below ~1.2 in A&D, fade the sector beta and rotate back to defensives.